# Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

> **NCT01962571** · PHASE3 · COMPLETED · sponsor: **University Eye Hospital, Freiburg** · enrollment: 108 (actual)

## Conditions studied

- Optic Neuritis

## Interventions

- **DRUG:** Erythropoietin alfa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01962571
- **Lead sponsor:** University Eye Hospital, Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-25
- **Primary completion:** 2018-06-20
- **Final completion:** 2019-11-26
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2019-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01962571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01962571, "Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01962571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*